Dihomo-γ-Linolenic Acid (20:3n-6)—Metabolism, Derivatives, and Potential Significance in Chronic Inflammation
Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsat...
Saved in:
| Published in | International journal of molecular sciences Vol. 24; no. 3; p. 2116 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
20.01.2023
MDPI |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from γ-linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body’s DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted. |
|---|---|
| AbstractList | Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from γ-linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body’s DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted. Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from γ-linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body's DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted.Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from γ-linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body's DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted. Dihomo- γ -linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from γ -linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body’s DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted. Dihomo- -linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract. DGLA can be produced by cultured fungi or be obtained via endogenous conversion from -linolenic acid (GLA)-rich vegetable oils. Several disease states are characterized by abnormally low DGLA levels in the body, while others can feature elevated levels. A defect in the activity of ∆6-desaturase and/or ∆5-desaturase may be one factor in the initiation and progression of these conditions. The potential of GLA and DGLA administrations as curative or ameliorating therapies in inflammatory conditions and malignancies appears modest at best. Manipulations with ∆6- and ∆5-desaturase inhibitors or combinations of long-chain PUFA supplements with n-3 PUFAs could provide a way to modify the body's DGLA and ARA production and the concentrations of their pro- and anti-inflammatory mediators. However, clinical data remain scarce and further well-designed studies should be actively promoted. |
| Author | Nieminen, Petteri Mustonen, Anne-Mari |
| AuthorAffiliation | 1 Department of Environmental and Biological Sciences, Faculty of Science, Forestry and Technology, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, Finland 2 Faculty of Health Sciences, Institute of Biomedicine, School of Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland |
| AuthorAffiliation_xml | – name: 2 Faculty of Health Sciences, Institute of Biomedicine, School of Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland – name: 1 Department of Environmental and Biological Sciences, Faculty of Science, Forestry and Technology, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, Finland |
| Author_xml | – sequence: 1 givenname: Anne-Mari orcidid: 0000-0003-2266-2518 surname: Mustonen fullname: Mustonen, Anne-Mari – sequence: 2 givenname: Petteri surname: Nieminen fullname: Nieminen, Petteri |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36768438$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkcuKFDEUhoOMOBfduZYCNyN0aS6VurgYGHqccaBFQV2HVPpk-jSppE2qG2bnQ_gmvocP4ZOYnou0g6sTON__85_8h2TPBw-EPGf0tRAdfYPLIfGKCs5Y_YgcsIrzktK62dt575PDlJaUcsFl94Tsi7qp20q0B2R1hoswhPLXz3KGPjjwaIpTg_PimNO3wpf1q9_ff3yAUffBYRomxRlE3OgRN5Amhfbz4lMYwY-oXfEZrzxaNNobKNAX00UMW79Lb50ehiwK_il5bLVL8OxuHpGv5---TN-Xs48Xl9PTWWkqxscSKuhrBpRBwxsNtu20lXNpte0pb2WGRCdZ01tdgRWsFZJSCqIDqYWppRBH5OTWd7XuB5ibHDFqp1YRBx2vVdCo_t14XKirsFFdx2rJeTY4vjOI4dsa0qgGTAac0x7COineNLJmkt2gLx-gy7COPp-3paqOMSlopl7sJvob5b6MDPBbwMSQUgSrDI43n5YDolOMqm3jarfxLJo8EN37_hf_A6FFrj8 |
| CitedBy_id | crossref_primary_10_1016_j_jbc_2024_107168 crossref_primary_10_1016_j_jff_2024_106554 crossref_primary_10_1016_j_scitotenv_2024_173222 crossref_primary_10_1016_j_biochi_2024_09_015 crossref_primary_10_3390_plants13243515 crossref_primary_10_1017_S0007114524000382 crossref_primary_10_52973_rcfcv_e34362 crossref_primary_10_3390_biom14080899 crossref_primary_10_3390_ijms242115693 crossref_primary_10_1016_j_jep_2023_117670 crossref_primary_10_1016_j_psj_2025_104820 crossref_primary_10_3390_nu16223812 crossref_primary_10_1093_jas_skae070 crossref_primary_10_1080_21688370_2024_2435552 crossref_primary_10_3389_fendo_2024_1391826 crossref_primary_10_1186_s13075_023_03260_y crossref_primary_10_3390_biomedicines11123320 crossref_primary_10_1016_j_plefa_2024_102629 crossref_primary_10_3390_nu15153465 crossref_primary_10_1016_j_sajb_2024_12_023 crossref_primary_10_1016_j_chemosphere_2024_141654 crossref_primary_10_1016_j_aninu_2024_08_008 crossref_primary_10_3390_md23020086 crossref_primary_10_3390_metabo14120673 crossref_primary_10_1002_slct_202405605 crossref_primary_10_3389_fmicb_2025_1500961 crossref_primary_10_3389_fmed_2023_1083351 crossref_primary_10_3390_nu16183130 crossref_primary_10_55544_jrasb_4_1_10 crossref_primary_10_1186_s12711_025_00961_7 crossref_primary_10_3390_foods12091784 crossref_primary_10_3390_nu17050821 crossref_primary_10_3389_fendo_2023_1302965 crossref_primary_10_1002_jcp_70000 crossref_primary_10_3390_ph17070895 crossref_primary_10_1097_MCO_0000000000001006 crossref_primary_10_1007_s00394_025_03647_4 crossref_primary_10_2106_JBJS_23_00805 crossref_primary_10_3390_ph17091198 crossref_primary_10_1016_j_jff_2024_106427 |
| Cites_doi | 10.1046/j.1365-2133.1999.02771.x 10.1111/obr.12280 10.1155/2021/8848161 10.1371/journal.pone.0047567 10.1007/s11745-003-1086-9 10.1038/s41598-019-39232-z 10.5551/jat.No430 10.1017/S0007114514002815 10.1002/mnfr.202200351 10.3390/ijms21030741 10.1128/AEM.01008-07 10.1186/1476-511X-11-25 10.3390/biom11020241 10.1007/s11745-012-3664-3 10.1007/s11745-013-3874-3 10.1007/s10654-007-9218-y 10.1016/j.redox.2017.01.016 10.1016/j.plefa.2018.03.004 10.3390/nu13103475 10.1136/thorax.2003.009498 10.1038/217069a0 10.1016/j.bbadis.2019.06.011 10.1007/s11745-007-3129-2 10.1017/S000711451300425X 10.1186/s12944-018-0947-6 10.1002/ejlt.201400430 10.1136/adc.75.6.494 10.4049/jimmunol.171.11.6080 10.1507/endocrj.EJ20-0564 10.1186/s12944-017-0542-2 10.1002/anr.1780321013 10.1007/s11746-000-0178-2 10.1124/jpet.119.259846 10.1186/s13075-023-02998-9 10.1272/jnms.JNMS.2021_88-317 10.1093/jn/137.2.368 10.1186/s12944-017-0637-9 10.1016/S1995-7645(14)60199-1 10.1007/s00216-012-6226-x 10.1016/j.jaci.2013.12.1087 10.4239/wjd.v6.i2.245 10.3389/fmicb.2020.546230 10.1016/j.ejphar.2016.04.020 10.1093/rheumatology/ker119 10.1007/s000110050137 10.1136/bmjdrc-2018-000632 10.1016/j.orcp.2016.02.004 10.1371/journal.pone.0097001 10.1016/j.clnu.2022.02.012 10.1007/s10753-023-01816-3 10.1016/0952-3278(95)90066-7 10.1016/0163-7827(81)90117-X 10.2169/internalmedicine.0816-18 10.3390/nu9040325 10.1128/aem.59.12.4300-4304.1993 10.1007/s11926-021-01007-9 10.2147/CMAR.S185601 10.1016/j.jaad.2017.12.024 10.1080/10446670410001670445 10.1016/j.jpba.2014.02.014 10.1093/jn/127.8.1435 10.1002/hep.23229 10.1016/j.ebiom.2015.09.004 10.3945/ajcn.115.112847 10.3748/wjg.v21.i8.2405 10.1093/jn/128.9.1411 10.1093/ajcn/nqac150 10.1038/s41598-023-36697-x 10.1007/s002280050273 10.1016/j.tranon.2021.101207 10.1007/s12325-014-0093-0 |
| ContentType | Journal Article |
| Copyright | 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
| Copyright_xml | – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.3390/ijms24032116 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1422-0067 |
| ExternalDocumentID | PMC9916522 36768438 10_3390_ijms24032116 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Academy of Finland grantid: 322429 – fundername: Academy of Finland grantid: #322429 |
| GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c412t-e4eb61e01e727aef89af5d5fafb0285c4139517bfa4ef31835000e39e5a3c6533 |
| IEDL.DBID | M48 |
| ISSN | 1422-0067 1661-6596 |
| IngestDate | Thu Aug 21 18:38:31 EDT 2025 Thu Jul 10 19:09:47 EDT 2025 Fri Jul 25 20:24:31 EDT 2025 Mon Jul 21 05:58:45 EDT 2025 Tue Jul 01 02:03:18 EDT 2025 Thu Apr 24 22:56:42 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | oxylipin inflammation dihomo-γ-linolenic acid n-6 PUFA DGLA lipid mediator |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c412t-e4eb61e01e727aef89af5d5fafb0285c4139517bfa4ef31835000e39e5a3c6533 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-2266-2518 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms24032116 |
| PMID | 36768438 |
| PQID | 2774911530 |
| PQPubID | 2032341 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9916522 proquest_miscellaneous_2775615122 proquest_journals_2774911530 pubmed_primary_36768438 crossref_citationtrail_10_3390_ijms24032116 crossref_primary_10_3390_ijms24032116 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20230120 |
| PublicationDateYYYYMMDD | 2023-01-20 |
| PublicationDate_xml | – month: 1 year: 2023 text: 20230120 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | International journal of molecular sciences |
| PublicationTitleAlternate | Int J Mol Sci |
| PublicationYear | 2023 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Kawashima (ref_65) 2008; 43 Wang (ref_75) 2018; 10 Riezzo (ref_30) 2014; 112 Sweatman (ref_51) 1968; 217 Henz (ref_52) 1999; 140 Innes (ref_4) 2018; 132 Jareonkitmongkol (ref_57) 1993; 59 ref_54 Markovitch (ref_59) 2015; 117 Mariamenatu (ref_67) 2021; 2021 Pitel (ref_18) 2007; 137 Scoville (ref_29) 2019; 9 Hederos (ref_64) 1996; 75 Serhiyenko (ref_69) 2015; 6 Woods (ref_35) 2004; 59 ref_15 Matsuda (ref_27) 2017; 11 Fan (ref_1) 1998; 128 Gallagher (ref_42) 2019; 1865 Harmon (ref_73) 2003; 38 Wang (ref_40) 2012; 11 Mustonen (ref_6) 2021; 23 Pillinger (ref_47) 2003; 171 Okamura (ref_17) 2021; 68 Bahmani (ref_61) 2014; 7 Vidakovic (ref_21) 2016; 103 ref_24 ref_68 Kritz (ref_41) 1997; 52 Wachira (ref_76) 2014; 111 ref_63 Yazawa (ref_60) 2007; 73 Bouhajja (ref_19) 2017; 16 Pang (ref_44) 2021; 14 Navarro (ref_32) 2000; 27 Antimanon (ref_56) 2020; 11 Kompauer (ref_36) 2008; 23 Yang (ref_43) 2015; 21 Ni (ref_12) 2015; 2 Puri (ref_25) 2009; 50 Johnson (ref_62) 1997; 127 ref_33 Yang (ref_45) 2017; 11 ref_74 Ouchi (ref_23) 2017; 16 Wasserman (ref_50) 1980; 214 Fekete (ref_11) 2015; 16 Chen (ref_14) 2019; 7 Ni (ref_46) 1997; 46 Wendell (ref_7) 2014; 133 Tsurutani (ref_13) 2018; 57 Abidi (ref_72) 2014; 8 Fussbroich (ref_49) 2019; 18 Simon (ref_39) 2014; 31 Vakharia (ref_53) 2018; 78 Perreault (ref_10) 2014; 49 Strassburg (ref_5) 2012; 404 Macfarlane (ref_8) 2011; 50 Hooper (ref_71) 2018; 7 Kanda (ref_38) 2021; 88 Sergeant (ref_2) 2016; 785 Baker (ref_34) 1989; 32 Bruderlein (ref_31) 1981; 20 Zhang (ref_20) 2014; 95 Ziboh (ref_66) 2004; 11 Wahab (ref_28) 2022; 41 Tanaka (ref_55) 2012; 47 ref_3 Das (ref_16) 1995; 52 Tuomainen (ref_26) 2022; 116 Kawashima (ref_58) 2000; 77 Mirsadraee (ref_37) 2016; 15 ref_48 Takai (ref_22) 2009; 16 Takagahara (ref_77) 2019; 371 Meuronen (ref_70) 2022; 66 Bamford (ref_9) 2013; 4 |
| References_xml | – volume: 140 start-page: 685 year: 1999 ident: ref_52 article-title: Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema publication-title: Br. J. Dermatol. doi: 10.1046/j.1365-2133.1999.02771.x – volume: 16 start-page: 488 year: 2015 ident: ref_11 article-title: Long-chain polyunsaturated fatty acid status in obesity: A systematic review and meta-analysis publication-title: Obes. Rev. doi: 10.1111/obr.12280 – volume: 2021 start-page: 8848161 year: 2021 ident: ref_67 article-title: Overconsumption of omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: The disturbing factor for their “balanced antagonistic metabolic functions” in the human body publication-title: J. Lipids doi: 10.1155/2021/8848161 – ident: ref_74 doi: 10.1371/journal.pone.0047567 – volume: 38 start-page: 469 year: 2003 ident: ref_73 article-title: Effect of the ∆6-desaturase inhibitor SC-26196 on PUFA metabolism in human cells publication-title: Lipids doi: 10.1007/s11745-003-1086-9 – volume: 9 start-page: 2882 year: 2019 ident: ref_29 article-title: Serum polyunsaturated fatty acids correlate with serum cytokines and clinical disease activity in Crohn’s disease publication-title: Sci. Rep. doi: 10.1038/s41598-019-39232-z – volume: 15 start-page: 168 year: 2016 ident: ref_37 article-title: Effect of Borago officinalis extract on moderate persistent asthma: A phase two randomized, double blind, placebo-controlled clinical trial publication-title: Tanaffos – volume: 16 start-page: 480 year: 2009 ident: ref_22 article-title: Anti-atherosclerotic effects of dihomo-γ-linolenic acid in ApoE-deficient mice publication-title: J. Atheroscler. Thromb. doi: 10.5551/jat.No430 – volume: 112 start-page: 1787 year: 2014 ident: ref_30 article-title: Lipidomic analysis of fatty acids in erythrocytes of coeliac patients before and after a gluten-free diet intervention: A comparison with healthy subjects publication-title: Br. J. Nutr. doi: 10.1017/S0007114514002815 – volume: 66 start-page: e2200351 year: 2022 ident: ref_70 article-title: The FADS1 rs174550 genotype modifies the n-3 and n-6 PUFA and lipid mediator responses to a high alpha-linolenic acid and high linoleic acid diets publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.202200351 – volume: 8 start-page: HC19 year: 2014 ident: ref_72 article-title: Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma publication-title: J. Clin. Diagn. Res. – ident: ref_54 doi: 10.3390/ijms21030741 – volume: 73 start-page: 6965 year: 2007 ident: ref_60 article-title: Heterologous production of dihomo-γ-linolenic acid in Saccharomyces cerevisiae publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.01008-07 – volume: 7 start-page: CD011094 year: 2018 ident: ref_71 article-title: Omega-6 fats for the primary and secondary prevention of cardiovascular disease publication-title: Cochrane Database Syst. Rev. – volume: 11 start-page: 25 year: 2012 ident: ref_40 article-title: Multiple roles of dihomo-γ-linolenic acid against proliferation diseases publication-title: Lipids Health Dis. doi: 10.1186/1476-511X-11-25 – ident: ref_3 doi: 10.3390/biom11020241 – volume: 47 start-page: 643 year: 2012 ident: ref_55 article-title: Oral supplementation with dihomo-γ-linolenic acid (DGLA)-enriched oil increases serum DGLA content in healthy adults publication-title: Lipids doi: 10.1007/s11745-012-3664-3 – volume: 49 start-page: 255 year: 2014 ident: ref_10 article-title: Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults publication-title: Lipids doi: 10.1007/s11745-013-3874-3 – volume: 23 start-page: 175 year: 2008 ident: ref_36 article-title: Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-007-9218-y – volume: 11 start-page: 653 year: 2017 ident: ref_45 article-title: Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells publication-title: Redox Biol. doi: 10.1016/j.redox.2017.01.016 – volume: 132 start-page: 41 year: 2018 ident: ref_4 article-title: Omega-6 fatty acids and inflammation publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/j.plefa.2018.03.004 – ident: ref_24 doi: 10.3390/nu13103475 – volume: 59 start-page: 105 year: 2004 ident: ref_35 article-title: Fatty acid levels and risk of asthma in young adults publication-title: Thorax doi: 10.1136/thorax.2003.009498 – volume: 217 start-page: 69 year: 1968 ident: ref_51 article-title: Effects of prostaglandins on human bronchial muscle publication-title: Nature doi: 10.1038/217069a0 – volume: 1865 start-page: 2538 year: 2019 ident: ref_42 article-title: Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2019.06.011 – volume: 43 start-page: 37 year: 2008 ident: ref_65 article-title: Oral administration of dihomo-γ-linolenic acid prevents development of atopic dermatitis in NC/Nga mice publication-title: Lipids doi: 10.1007/s11745-007-3129-2 – volume: 111 start-page: 1652 year: 2014 ident: ref_76 article-title: N-3 fatty acids affect haemostasis but do not increase the risk of bleeding: Clinical observations and mechanistic insights publication-title: Br. J. Nutr. doi: 10.1017/S000711451300425X – volume: 18 start-page: 16 year: 2019 ident: ref_49 article-title: A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma publication-title: Lipids Health Dis. doi: 10.1186/s12944-018-0947-6 – volume: 117 start-page: 760 year: 2015 ident: ref_59 article-title: A novel source of dihomo-γ-linolenic acid: Possibilities and limitations of DGLA production in the high-density cultures of the Δ5 desaturase-mutant microalga Lobosphaera incisa publication-title: Eur. J. Lipid Sci. Technol. doi: 10.1002/ejlt.201400430 – volume: 75 start-page: 494 year: 1996 ident: ref_64 article-title: Epogam evening primrose oil treatment in atopic dermatitis and asthma publication-title: Arch. Dis. Child. doi: 10.1136/adc.75.6.494 – volume: 171 start-page: 6080 year: 2003 ident: ref_47 article-title: Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation publication-title: J. Immunol. doi: 10.4049/jimmunol.171.11.6080 – volume: 68 start-page: 421 year: 2021 ident: ref_17 article-title: Low circulating dihomo-gamma-linolenic acid is associated with diabetic retinopathy: A cross sectional study of KAMOGAWA-DM cohort study publication-title: Endocr. J. doi: 10.1507/endocrj.EJ20-0564 – volume: 16 start-page: 150 year: 2017 ident: ref_23 article-title: Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure publication-title: Lipids Health Dis. doi: 10.1186/s12944-017-0542-2 – volume: 214 start-page: 68 year: 1980 ident: ref_50 article-title: Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2 publication-title: J. Pharmacol. Exp. Ther. – volume: 32 start-page: 1273 year: 1989 ident: ref_34 article-title: Suppression of human synovial cell proliferation by dihomo-γ-linolenic acid publication-title: Arthritis Rheum. doi: 10.1002/anr.1780321013 – volume: 77 start-page: 1135 year: 2000 ident: ref_58 article-title: Industrial production of dihomo-γ-linolenic acid by a Δ5 desaturase-defective mutant of Mortierella alpina 1S-4 fungus publication-title: J. Am. Oil Chem. Soc. doi: 10.1007/s11746-000-0178-2 – volume: 371 start-page: 290 year: 2019 ident: ref_77 article-title: A novel orally available delta-5 desaturase inhibitor prevents atherosclerotic lesions accompanied by changes in fatty acid composition and eicosanoid production in ApoE knockout mice publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.119.259846 – ident: ref_63 doi: 10.1186/s13075-023-02998-9 – volume: 88 start-page: 171 year: 2021 ident: ref_38 article-title: Nutrition and atopic dermatitis publication-title: J. Nippon Med. Sch. doi: 10.1272/jnms.JNMS.2021_88-317 – volume: 137 start-page: 368 year: 2007 ident: ref_18 article-title: At low doses, a γ-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats publication-title: J. Nutr. doi: 10.1093/jn/137.2.368 – volume: 16 start-page: 241 year: 2017 ident: ref_19 article-title: Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction publication-title: Lipids Health Dis. doi: 10.1186/s12944-017-0637-9 – volume: 7 start-page: S22 year: 2014 ident: ref_61 article-title: The chemical composition, botanical characteristic and biological activities of Borago officinalis: A review publication-title: Asian Pac. J. Trop. Med. doi: 10.1016/S1995-7645(14)60199-1 – volume: 404 start-page: 1413 year: 2012 ident: ref_5 article-title: Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: Application in cardiac surgery publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-012-6226-x – volume: 133 start-page: 1255 year: 2014 ident: ref_7 article-title: Fatty acids, inflammation, and asthma publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2013.12.1087 – volume: 6 start-page: 245 year: 2015 ident: ref_69 article-title: Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? publication-title: World J. Diabetes doi: 10.4239/wjd.v6.i2.245 – volume: 11 start-page: 546230 year: 2020 ident: ref_56 article-title: Physiological traits of dihomo-γ-linolenic acid production of the engineered Aspergillus oryzae by comparing mathematical models publication-title: Front. Microbiol. doi: 10.3389/fmicb.2020.546230 – volume: 785 start-page: 77 year: 2016 ident: ref_2 article-title: Gamma-linolenic acid, dihommo-gamma linolenic, eicosanoids and inflammatory processes publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2016.04.020 – volume: 50 start-page: 1672 year: 2011 ident: ref_8 article-title: Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: A systematic review publication-title: Rheumatology doi: 10.1093/rheumatology/ker119 – volume: 46 start-page: S124 year: 1997 ident: ref_46 article-title: DGLA discoordinately suppresses IL-1 induced metalloproteinase mRNA levels in human synovial fibroblasts publication-title: Inflamm. Res. doi: 10.1007/s000110050137 – volume: 7 start-page: e000632 year: 2019 ident: ref_14 article-title: Individual free fatty acids have unique associations with inflammatory biomarkers, insulin resistance and insulin secretion in healthy and gestational diabetic pregnant women publication-title: BMJ Open Diab. Res. Care doi: 10.1136/bmjdrc-2018-000632 – volume: 11 start-page: 34 year: 2017 ident: ref_27 article-title: Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis publication-title: Obes. Res. Clin. Pract. doi: 10.1016/j.orcp.2016.02.004 – ident: ref_15 doi: 10.1371/journal.pone.0097001 – volume: 41 start-page: 847 year: 2022 ident: ref_28 article-title: Maternal polyunsaturated fatty acid concentrations during pregnancy and childhood liver fat accumulation publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2022.02.012 – ident: ref_33 doi: 10.1007/s10753-023-01816-3 – volume: 4 start-page: CD004416 year: 2013 ident: ref_9 article-title: Oral evening primrose oil and borage oil for eczema publication-title: Cochrane Database Syst. Rev. – volume: 52 start-page: 387 year: 1995 ident: ref_16 article-title: Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/0952-3278(95)90066-7 – volume: 20 start-page: 625 year: 1981 ident: ref_31 article-title: Fatty acid profiles of serum phospholipids in patients suffering rheumatoid arthritis publication-title: Prog. Lipid Res. doi: 10.1016/0163-7827(81)90117-X – volume: 57 start-page: 2929 year: 2018 ident: ref_13 article-title: Increased serum dihomo-γ-linolenic acid levels are associated with obesity, body fat accumulation, and insulin resistance in Japanese patients with type 2 diabetes publication-title: Intern. Med. doi: 10.2169/internalmedicine.0816-18 – ident: ref_68 doi: 10.3390/nu9040325 – volume: 59 start-page: 4300 year: 1993 ident: ref_57 article-title: A novel ∆5-desaturase-defective mutant of Mortierella alpina 1S-4 and its dihomo-γ-linolenic acid productivity publication-title: Appl. Environ. Microbiol. doi: 10.1128/aem.59.12.4300-4304.1993 – volume: 23 start-page: 41 year: 2021 ident: ref_6 article-title: Fatty acids and oxylipins in osteoarthritis and rheumatoid arthritis—A complex field with significant potential for future treatments publication-title: Curr. Rheumatol. Rep. doi: 10.1007/s11926-021-01007-9 – volume: 10 start-page: 6779 year: 2018 ident: ref_75 article-title: Delta-6-desaturase inhibitor enhances radiation therapy in glioblastoma in vitro and in vivo publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S185601 – volume: 78 start-page: S76 year: 2018 ident: ref_53 article-title: New therapies for atopic dermatitis: Additional treatment classes publication-title: J. Am. Acad. Dermatol. doi: 10.1016/j.jaad.2017.12.024 – volume: 11 start-page: 13 year: 2004 ident: ref_66 article-title: Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: Possible implication in asthma publication-title: Clin. Dev. Immunol. doi: 10.1080/10446670410001670445 – volume: 95 start-page: 85 year: 2014 ident: ref_20 article-title: Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC–MS and chemometrics approach publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2014.02.014 – volume: 127 start-page: 1435 year: 1997 ident: ref_62 article-title: Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans publication-title: J. Nutr. doi: 10.1093/jn/127.8.1435 – volume: 50 start-page: 1827 year: 2009 ident: ref_25 article-title: The plasma lipidomic signature of nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.23229 – volume: 2 start-page: 1513 year: 2015 ident: ref_12 article-title: Circulating unsaturated fatty acids delineate the metabolic status of obese individuals publication-title: EBioMedicine doi: 10.1016/j.ebiom.2015.09.004 – volume: 103 start-page: 1017 year: 2016 ident: ref_21 article-title: Maternal plasma PUFA concentrations during pregnancy and childhood adiposity: The Generation R Study publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.115.112847 – volume: 27 start-page: 298 year: 2000 ident: ref_32 article-title: Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids publication-title: J. Rheumatol. – volume: 21 start-page: 2405 year: 2015 ident: ref_43 article-title: Expression profile of polyunsaturated fatty acids in colorectal cancer publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v21.i8.2405 – volume: 128 start-page: 1411 year: 1998 ident: ref_1 article-title: Importance of dietary γ-linolenic acid in human health and nutrition publication-title: J. Nutr. doi: 10.1093/jn/128.9.1411 – volume: 116 start-page: 759 year: 2022 ident: ref_26 article-title: Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/nqac150 – ident: ref_48 doi: 10.1038/s41598-023-36697-x – volume: 52 start-page: 191 year: 1997 ident: ref_41 article-title: Prostaglandin E1 decreases human arterial accumulation of radiolabeled apo B-containing lipoproteins in vivo publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s002280050273 – volume: 14 start-page: 101207 year: 2021 ident: ref_44 article-title: Delta-5-desaturase: A novel therapeutic target for cancer management publication-title: Transl. Oncol. doi: 10.1016/j.tranon.2021.101207 – volume: 31 start-page: 180 year: 2014 ident: ref_39 article-title: Gamma-linolenic acid levels correlate with clinical efficacy of evening primrose oil in patients with atopic dermatitis publication-title: Adv. Ther. doi: 10.1007/s12325-014-0093-0 |
| SSID | ssj0023259 |
| Score | 2.5444794 |
| SecondaryResourceType | review_article |
| Snippet | Dihomo-γ-linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic... Dihomo- -linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic... Dihomo- γ -linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 2116 |
| SubjectTerms | 8,11,14-Eicosatrienoic Acid Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Arachidonic Acid Arthritis Atherosclerosis Biosynthesis Body fat Chronic Disease Diabetes Diabetic retinopathy Disease Eczema Fatty Acid Desaturases - metabolism Fatty acids Fatty Acids, Omega-6 Humans Inflammation Inflammation - drug therapy Inflammation - metabolism Insulin resistance Lipids Metabolism Metabolites Obesity Overweight Plasma Polyunsaturated fatty acids Review Smooth muscle |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dahQxFA62UuiNVO3P2iopKCg2dCZ_s-ONFGupQkXQwt4NmUnSjnQza2da8M6H8E18Dx_CJ_Gcmdlt19LeDcyBhJyT5DvJyfcR8jwBiC19YhlgWUhQbGRYCskPM7FP9VDnANLxvfPRJ314LD-O1Kg_cKv7ssrpmtgu1LYq8Ix8lwNOgYmpRPR28p2hahTervYSGgvkPlKXYUlXMrpKuARvxdJi2IOYVqnuCt8FpPm75bdxjVR0kP_o-S3pBs78v1zy2v5zsEIe9MCR7nWefkjuufCILHVSkj8ek8l-eVqNK_bnN4P0Ei_by4LuFaWlL3n0RgSmX_39-evINeD0s7Ie79B9iL3Llva73qEmWPq5arB0CBr5Up4ELCHCiKBloD2DLv0QPARQ99hxlRwfvP_67pD1agqskDFvmJMu17GLYgeQxTg_TI1XVnnjc8AYCowEoK0k90Y6jzMdpRKcSJ0yotCACtfIYqiC2yA0SorcGi9SmURSOg6fViXcQgsp5IvDAXk9HdCs6KnGUfHiLIOUA4c_uz78A_JiZj3pKDZusdua-ibrJ1qdXYXFgGzPfsMUwXsPE1x10dooBG6cD8h658pZQ0hYN5QCupzMOXlmgPTb839CedrScCOyBvT65O5ubZJlVKjHUxsebZHF5vzCPQUc0-TP2mD9B2u98wg priority: 102 providerName: ProQuest |
| Title | Dihomo-γ-Linolenic Acid (20:3n-6)—Metabolism, Derivatives, and Potential Significance in Chronic Inflammation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36768438 https://www.proquest.com/docview/2774911530 https://www.proquest.com/docview/2775615122 https://pubmed.ncbi.nlm.nih.gov/PMC9916522 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ta9RAEB76guCX4nuvrccKCopdzSW72UQQqbZnFa4U9eC-hU2yayN3G9tLi_1d_g9_kzNJLvSsgl9CYCdM2JnZfZ59mQF4rBBiC6tyjlgWCUruaR4j-eF6YOMwClME6XTfeXQUHo7Fx4mcrMCi2mjbgfO_UjuqJzU-m774cXr5BgP-NTFOpOwvi2-zOaWVQy4TrsI6zkmKQnQkuv0EhA112TRa8OA0QDdH4K99vTw5XUOcfx6cvDITDW_BRgsh2V5j89uwYtwduNEUlby8C26_OClnJf_1kyPRpG33ImN7WZGzp773KnA8fMZHpkLjT4v5bJftow9e1Om_57tMu5wdlxUdIUIVn4uvjo4SkWewwrE2ky774Cw6UnPp8R6Mhwdf3h3ytqoCz8TAr7gRJg0HxhsYhC7a2CjWVubSapsi1pAoFCDqUqnVwliKeCqZYILYSB1kIaLD-7DmSmc2gXkqS3Ntg1goTwjj42sulZ-jhhh5Y9SD54vuTLI25ThVvpgmSD2o85Ornd-DJ5309ybVxj_kdhaWSRb-kvgIY3HcloHXg0ddM4YK7X9oZ8rzWkYSgPP9HjxoDNkposR1kQjwl9WSiTsBSsO93OKKkzodNyFsRLFb_6F3G25SuXpawvG9HVirzs7NQwQ1VdqHVTVR-IyG7_uw_vbg6PhTn6YZ2a89-TcVi_ok |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgQXxD_bFjASlUDUauKfZIOEUMVS7dJuhUQr7S11EpsGdZ2FpKDeeAiegwvvwUPwJMzkZ9sFwa23SBnJ1vgbzzf2eIaQxyFQbGnDjAGXhQAl8zSLIPhh2rdR0A8SIOn43nm8FwwP5JuJmiyR791bGEyr7PbEeqPOihTPyDc58BQwTCW8l7OPDLtG4e1q10KjgcWOOf0CIVv5YjSA9V3nfPv1_qsha7sKsFT6vGJGmiTwjecbcN3a2H6krcqU1TYBX6tASADrCBOrpbGIeGwZYERklBZpoPAAFLb8S-B4PbSocHIW4AleN2fzweexQEVBk2gvRORt5h-mJZa-g3grWHSBf_HaP9Mzz_m77evkWktU6VaDrBtkybib5HLTuvL0FpkN8qNiWrCfPxiEs3i5n6d0K80z-oR7z4VjwdNfX7-NTQUgO87L6QYdANY_12XGyw2qXUbfFhWmKsEg7_L3DlOWEIE0d7St2EtHzgJgm8eVt8nBhej5Dll2hTP3CPXCNMm0FZEMPSkNh89MhTyDESKIT_s98qxTaJy2pc2xw8ZxDCEOqj8-r_4eWZ9Lz5qSHv-QW-vWJm4Nu4zPYNgjj-a_wSTxnkU7U5zUMgqJIuc9crdZyvlAWCCvLwVMOVxY5LkAlvte_OPyo7rsNzJ5YMsr_5_WQ3JluD_ejXdHezur5CoHVOKJEffWyHL16cTcBw5VJQ9q4FJyeNGW8hs3lTAA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqoiIuiH8WChiJSiBqbWLHzqYSQlWXVZfSqhJU2ltwEpsGdZ2FpKDeeIi-CTcegofgSZjJz7YLgltvkTKSrfE3nm_s8QwhT0Kg2IENMwZcFgKUzNMsguCHad9GaqASIOn43nl3T20fBK8ncrJEfnRvYTCtstsT6406K1I8I-9z4ClgmFJ4fdumRewPRy9nnxh2kMKb1q6dRgORHXPyFcK38sV4CGu9xvno1butbdZ2GGBp4POKmcAkyjeeb8CNa2MHkbYyk1bbBPyuBCEBDCRMrA6MRfRj-wAjIiO1SJXEw1DY_i-FQvpoY-HkLNgTvG7U5oP_Y0pGqkm6FyLy-vnHaYll8CD2Uovu8C-O-2eq5jnfN7pGrraklW42KLtOloy7QVaaNpYnN8lsmB8W04L9_M4gtMWL_jylm2me0afc2xCOqWe_vp3umgoAd5SX03U6BNx_qUuOl-tUu4zuFxWmLcEgb_MPDtOXEI00d7St3kvHzgJ4m4eWt8jBhej5Nll2hTN3CfXCNMm0FVEQekFgOHxmMuQZjBBBrDrokeedQuO0LXOO3TaOYgh3UP3xefX3yNpcetaU9_iH3Gq3NnFr5GV8BskeeTz_DeaJdy7ameK4lpFIGjnvkTvNUs4HwmJ5g0DAlMOFRZ4LYOnvxT8uP6xLgCOrB-Z87__TekQug43Eb8Z7O_fJFQ6gxMMj7q2S5erzsXkAdKpKHta4peT9RRvKbyTLNDY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dihomo-%CE%B3-Linolenic+Acid+%2820%3A3n-6%29-Metabolism%2C+Derivatives%2C+and+Potential+Significance+in+Chronic+Inflammation&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Mustonen%2C+Anne-Mari&rft.au=Nieminen%2C+Petteri&rft.date=2023-01-20&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=24&rft.issue=3&rft_id=info:doi/10.3390%2Fijms24032116&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |